维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Bultink"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Glucocorticoid-induced osteo-porosis: update current pharmacotherapy and fu- ture directions 显示文摘	Bultink IE Baden M Lems WF	2013	Expert Opin Pharmacother2013，14，2：	1
2	Inflammatory Rheumatic Disorders and Bone显示文摘	Irene Bultink Marijn Vis Irene Horst-Bruinsma Willem Lems	2012	Current Rheumatology Reports2012，，3：	1
3	Advances in glucocorticoidinduced osteoporosis显示文摘	den Uyl D Bultink IE Lems WF	2011	Curr Rheumatol Rep2011，13，3：	1
4	Inflammatory rheumatic disorders and bone 显示文摘	Bultink IE Vis M van der Horst-Bruinsma IE	2012	Curr Rheumatol Rep2012，14，3：	1
5	Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events,disease activity,and organ damage in patients with systemic lupus erythematosus显示文摘	Bultink IE Teerlink T Heijst JA	2005	Ann Rheum Dis2005，64，9：	1
6	prevalence of anti risk factors for the meta- bolic syndrome in women with systemic lupus erythema- tosus显示文摘	Bultink IE	2008	Clin Exp Rheumatol2008，26，1：	1
7	Osteoarthritis and osteoporosis: what is theoverlap?显示文摘	Bultink IE Lems WF	2013	Curr Rheumatol Rep2013，15，5：	1
8	Osteoporosis and fractures in systemic lupus erythematosus 显示文摘	Bultink IE	2012	Arthritis Care & Research2012，64，1：	1
9	Inflammatory Rheumatic Disorders and Bone显示文摘	Bultink IE Vis M Vander Horst-Bruinsma 1E	2012	Curt Rheumatol Rep2012，14，3：	1
10	Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus显示文摘	Bultink IE Turkstra F Diamant M	2008	Clin Exp Rheumatol2008，26，1：	1
11	Advances in glucocorticoid-induced osteoporosis显示文摘	Den Uyl D Bultink IE Lems WF	2011	Curr Rheumatol Rep2011，13，3：	1
12	Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosns versus matched controls: a population-based study in the United Kingdom显示文摘	Bultink IE Harvey NC Lalmohamed A	2014	Osteoporos Int2014，25，4：	1
13	Osteoporosis and fractures in systemic lupus erythematosus显示文摘	Bultink IE	2012	Arthritis Care Res(Hoboken)2012，64，1：	1
14	In-flammatory rheumatic disorders and bone显示文摘	Bultink IE Vis M van der Horst-Bruinsma IE	2012	Curr RheumatolRep2012，14，3：	1
15	Advances in glucocorticoid-in- duced osteoporosis 显示文摘	den Uyl D Bultink IE Lems WF	2011	Curr Rheumatol Rep2011，13，3：	1
16	Advances in glucocorticoid-induced osteoporosis显示文摘	Den Uyl D Bultink IE Lems WF	2011	Curr Rheumatol Rep2011，13，3：	1
17	Osteoarthritis and osteopo- rosis:what is the overlap? 显示文摘	Bultink IE Lems WF	2013	Curr Rheumatol Rep2013，15，5：	1
18	Prevention of glucocorticoid- induced osteoporosis显示文摘	V&n Brussel MS Bultink IE Lems WF	2009	Expert Opin Pharmacother2009，10，6：	1
19	Raised plasma levels of asymmetric dimethlyarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus 显示文摘	Bultink IE Teerlink T Heijst JA	2005	Ann Rheum Dis2005，64，9：	1
20	Management of osteoporosis in rheumatoid arthritis patients显示文摘	Hoes JN Bultink IE Lems WF	2015	Expert Opin Pharmaco2015，16，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示